Smith & Nephew releases full-year report, appoints new CEO
British medtech company Smith & Nephew is on the rise on the London stock exchange, following a full-year report and announcement that a Siemens Healthineers manager has been brought in as CEO replacement.
by marketwire, translated by daniel pedersen
On Tuesday, British medtech company Smith & Nephew, a competitor of Coloplast within wound care, has announced a CEO replacement in connection with the release of its full-year financial figures. The double news has been rewarded well on the London stock exchange, sending the company up by 2.1 percent to GBP 12.04.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast starts share buyback program
For subscribers
Coloplast upgrades growth expectations following acquisition
For subscribers
.jpg&w=384&q=75)
